Form 4: Hims & Hers CTO Executes Stock Transactions

Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., reported the vesting of RSUs and subsequent sale of shares via a 10b5-1 plan.

Summary

• Mohamed Elshenawy, Chief Technology Officer of Hims & Hers Health, Inc. (HIMS), exercised options to acquire 282,597 shares of Class A Common Stock on June 15, 2026.
• The company withheld 151,534 shares at a price of $30.17 per share to satisfy tax obligations related to the RSU vesting.
• The reporting person sold 30,040 shares on June 17, 2026, at a price of $31.50 per share.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a routine administrative action related to executive compensation and pre-planned trading.

Positives

• The executive maintains a significant remaining stake of 101,023 shares following the reported transactions.
• The sale was executed under a pre-arranged 10b5-1 plan, which typically indicates a systematic approach to liquidity rather than a reaction to non-public information.

Negatives

• The transaction results in a net reduction of the executive's direct share ownership.

Risks

• Future share price volatility may impact the value of the remaining 1,130,000+ unvested RSUs held by the executive.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on historical insider transaction reporting.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and tax obligations, and is generally viewed as neutral by the market when pre-planned.

Comparison to Industry Standards

• The use of 10b5-1 plans is consistent with best practices for corporate governance among high-growth technology and healthcare companies.
• The tax withholding mechanism is standard for equity-based compensation plans in the U.S. public market.

Stakeholder Impact

• Minimal impact on shareholders as the sale was conducted via a pre-established 10b5-1 plan.

Next Steps

• Continued vesting of remaining RSU tranches as per the service-based schedule.

Key Dates

Keywords

HIMS, Hims & Hers Health, Insider Trading, Form 4, Mohamed Elshenawy, CTO, Equity Compensation